SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 21 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,984,976 | +4.7% | 5,082,000 | 0.0% | 0.04% | -4.8% |
| Q2 2023 | $8,580,143 | -37.4% | 5,082,000 | -28.2% | 0.04% | -39.1% |
| Q1 2023 | $13,695,632 | -24.7% | 7,080,000 | -51.2% | 0.07% | -22.5% |
| Q2 2022 | $18,198,000 | -4.5% | 14,500,000 | 0.0% | 0.09% | +71.2% |
| Q1 2022 | $19,049,000 | – | 14,500,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DLD Asset Management, LP | 10,370,000 | $18,432,675 | 1.98% |
| Worth Venture Partners, LLC | 1,431,000 | $2,536,677 | 1.50% |
| CSS LLC/IL | 8,197,000 | $14,535,142 | 0.95% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,198,000 | $9,252,647 | 0.20% |
| Warberg Asset Management LLC | 517,000 | $911,580 | 0.18% |
| BOOTHBAY FUND MANAGEMENT, LLC | 3,889,000 | $6,893,877 | 0.16% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,000,000 | $1,765,625 | 0.05% |
| Point72 Asset Management, L.P. | 9,007,000 | $15,925,009 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 5,082,000 | $8,984,976 | 0.04% |
| D. E. Shaw & Co., Inc. | 11,089,000 | $19,645,113 | 0.02% |